Disrupted latent inhibition in the rat with chronic amphetamine or haloperidol-induced supersensitivity: relationship to schizophrenic attention disorder - PubMed (original) (raw)
- PMID: 7196265
Disrupted latent inhibition in the rat with chronic amphetamine or haloperidol-induced supersensitivity: relationship to schizophrenic attention disorder
P R Solomon et al. Biol Psychiatry. 1981 Jun.
Abstract
Latent inhibition (LI) is an attentional process by which animals learn to ignore a stimulus that is repeatedly presented without reinforcement. This ability to tune out a motivationally irrelevant stimulus is disrupted by pharmacological manipulations producing hyperdopaminergic states. In Experiment I, LI was disrupted following five daily administrations of 4 mg/kg d-amphetamine. In Experiment II the disruptive effects of d-amphetamine were eliminated by concomitant administration of chlorpromazine. Experiment III showed that LI could also be disrupted with 1 mg/kg d-amphetamine coupled with dopamine receptor supersensitivity produced by prolonged pretreatment with haloperidol. These data suggest that pharmacological disruption of LI may provide an animal analogue of the defective stimulus filtering thought to characterize at least some forms of schizophrenia.
Similar articles
- Systemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidol.
Gaisler-Salomon I, Weiner I. Gaisler-Salomon I, et al. Psychopharmacology (Berl). 2003 Apr;166(4):333-42. doi: 10.1007/s00213-002-1311-z. Epub 2003 Feb 22. Psychopharmacology (Berl). 2003. PMID: 12599023 - Using the pharmacology of latent inhibition to model domains of pathology in schizophrenia and their treatment.
Weiner I, Arad M. Weiner I, et al. Behav Brain Res. 2009 Dec 7;204(2):369-86. doi: 10.1016/j.bbr.2009.05.004. Epub 2009 May 9. Behav Brain Res. 2009. PMID: 19433114 Review. - Construct validity of the animal latent inhibition model of selective attention deficits in schizophrenia.
Lubow RE. Lubow RE. Schizophr Bull. 2005 Jan;31(1):139-53. doi: 10.1093/schbul/sbi005. Epub 2005 Feb 16. Schizophr Bull. 2005. PMID: 15888432 Review.
Cited by
- Sensorimotor gating deficits in transgenic mice expressing a constitutively active form of Gs alpha.
Gould TJ, Bizily SP, Tokarczyk J, Kelly MP, Siegel SJ, Kanes SJ, Abel T. Gould TJ, et al. Neuropsychopharmacology. 2004 Mar;29(3):494-501. doi: 10.1038/sj.npp.1300309. Neuropsychopharmacology. 2004. PMID: 14694347 Free PMC article. - Morphometric and neurosecretory changes in supraoptic neurons after D-amphetamine treatment.
Bentura ML, Lazcano MA, Zahonero MC, Toledano A. Bentura ML, et al. J Neural Transm Gen Sect. 1992;89(1-2):81-92. doi: 10.1007/BF01245354. J Neural Transm Gen Sect. 1992. PMID: 1418869 - Cognitive judgment bias in the psychostimulant-induced model of mania in rats.
Rygula R, Szczech E, Kregiel J, Golebiowska J, Kubik J, Popik P. Rygula R, et al. Psychopharmacology (Berl). 2015 Feb;232(3):651-60. doi: 10.1007/s00213-014-3707-y. Epub 2014 Aug 14. Psychopharmacology (Berl). 2015. PMID: 25116482 Free PMC article. - Interaction of serotonin- and dopaminergic systems of the brain in mechanisms of latent inhibition in rats.
Loskutova LV, Luk'yanenko FYa, Il'yuchenok RYu. Loskutova LV, et al. Neurosci Behav Physiol. 1990 Nov-Dec;20(6):500-5. doi: 10.1007/BF01237275. Neurosci Behav Physiol. 1990. PMID: 2096321 - Sensitization to amphetamine, but not phencyclidine, disrupts prepulse inhibition and latent inhibition.
Tenn CC, Kapur S, Fletcher PJ. Tenn CC, et al. Psychopharmacology (Berl). 2005 Jul;180(2):366-76. doi: 10.1007/s00213-005-2253-z. Epub 2005 Apr 26. Psychopharmacology (Berl). 2005. PMID: 15856186